| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.11 | 0.6 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |